Does ALIROCUMAB Cause Hypersensitivity vasculitis? 9 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 9 reports of Hypersensitivity vasculitis have been filed in association with ALIROCUMAB (Praluent). This represents 0.0% of all adverse event reports for ALIROCUMAB.
9
Reports of Hypersensitivity vasculitis with ALIROCUMAB
0.0%
of all ALIROCUMAB reports
0
Deaths
2
Hospitalizations
How Dangerous Is Hypersensitivity vasculitis From ALIROCUMAB?
Of the 9 reports, 2 (22.2%) required hospitalization.
Is Hypersensitivity vasculitis Listed in the Official Label?
Yes, Hypersensitivity vasculitis is listed as a known adverse reaction in the official FDA drug label for ALIROCUMAB.
What Other Side Effects Does ALIROCUMAB Cause?
Myalgia (1,571)
Product dose omission (1,354)
Injection site pain (1,220)
Muscle spasms (1,113)
Arthralgia (993)
Fatigue (922)
Pain (892)
Pain in extremity (888)
Product dose omission issue (864)
Injection site bruising (821)
What Other Drugs Cause Hypersensitivity vasculitis?
ADALIMUMAB (147)
INFLIXIMAB (97)
METHOTREXATE (89)
ETANERCEPT (81)
RITUXIMAB (69)
RIVAROXABAN (67)
AZATHIOPRINE (66)
FUROSEMIDE (63)
PREDNISONE (63)
AMLODIPINE (54)
Which ALIROCUMAB Alternatives Have Lower Hypersensitivity vasculitis Risk?
ALIROCUMAB vs ALISKIREN
ALIROCUMAB vs ALISKIREN HEMIFUMARATE
ALIROCUMAB vs ALISKIREN\HYDROCHLOROTHIAZIDE
ALIROCUMAB vs ALIZAPRIDE
ALIROCUMAB vs ALLANTOIN